Orchestra BioMed(OBIO.US)

Last Updated 19:00:00 ET
longbridge loading

Orchestra BioMed (NASDAQ:OBIO) Given New $10.00 Price Target at B. Riley Financial

Market Beat·
US
OBIO
+3.02%
US
SBIO
+0.62%
US
PBE
-0.28%
Market Beat·
US
OBIO
+3.02%
US
SBIO
+0.62%
US
PBE
-0.28%

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates | OBIO Stock News

StockTitan·
US
OBIO
+3.02%
US
PBE
-0.28%
US
LABU
+0.17%
StockTitan·
US
OBIO
+3.02%
US
PBE
-0.28%
US
LABU
+0.17%

Orchestra Gains on $20M Buy-in from Medtronic

Baystreet·
US
OBIO
+3.02%
US
MDT
-1.06%
US
BIB
+0.08%
Baystreet·
US
OBIO
+3.02%
US
MDT
-1.06%
US
BIB
+0.08%

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 | OBIO Stock News

StockTitan·
US
OBIO
+3.02%
US
LABU
+0.17%
US
SBIO
+0.62%
StockTitan·
US
OBIO
+3.02%
US
LABU
+0.17%
US
SBIO
+0.62%
© 2026 Longbridge｜Disclaimer